| 1 | Hamartoma | 33.3% |
| 2 | Neoplasms, Hormone-Dependent | 33.3% |
| 3 | Neoplasms, Multiple Primary | 33.3% |
| 4 | Paraneoplastic Syndromes | 33.3% |
| 5 | Neoplasms, Second Primary | 33.3% |
| 6 | Carcinoma 256, Walker | 25.8% |
| 7 | Carcinoma, Ehrlich Tumor | 25.3% |
| 8 | Dermoid Cyst | 25.3% |
| 9 | Carcinoma, Lewis Lung | 25.3% |
| 10 | Neoplasms, Neuroepithelial | 24.1% |
| 11 | Gliomatosis cerebri | 24.1% |
| 12 | Neuroectodermal Tumors | 23.8% |
| 13 | Medulloblastoma | 23.4% |
| 14 | Abdominal Neoplasms | 23.1% |
| 15 | Follicular cyst | 23.1% |
| 16 | Head and Neck Neoplasms | 23.1% |
| 17 | leukemia | 23.1% |
| 18 | melanoma | 23.1% |
| 19 | Mucocele | 23.1% |
| 20 | Neoplasms, Germ Cell and Embryonal | 23.1% |
| 21 | Neoplasms, Glandular and Epithelial | 23.1% |
| 22 | Pilonidal Cyst | 23.1% |
| 23 | Soft Tissue Neoplasms | 23.1% |
| 24 | Thoracic Neoplasms | 23.1% |
| 25 | Thyroglossal Cyst | 23.1% |
| 26 | Synovial Cyst | 23.1% |
| 27 | Germ Cell Cancer | 23.1% |
| 28 | Carcinosarcoma | 22.4% |
| 29 | Hemangiosarcoma | 22.4% |
| 30 | Leukemia L1210 | 22.4% |
| 31 | Leukemia P388 | 22.4% |
| 32 | lymphangiosarcoma | 22.4% |
| 33 | Acanthoma | 22.4% |
| 34 | Adenoma, Acidophil | 22% |
| 35 | Ganglioneuroma | 22% |
| 36 | Glioma | 22% |
| 37 | Malignant Glioma | 22% |
| 38 | Sarcoma 180 | 21.6% |
| 39 | Carcinoid Tumor | 21.5% |
| 40 | Neurilemmoma | 21.5% |
| 41 | Hutchinson's Melanotic Freckle | 21.5% |
| 42 | Melanoma, Amelanotic | 21.5% |
| 43 | Melanoma, Experimental | 21.1% |
| 44 | Cyst | 21.1% |
| 45 | Neoplastic Processes | 21.1% |
| 46 | Neoplastic Syndromes, Hereditary | 21.1% |
| 47 | Pregnancy Complications, Neoplastic | 21.1% |
| 48 | Astrocytoma | 21% |
| 49 | Ependymoma | 21% |
| 50 | oligodendroglioma | 21% |
| 51 | Ganglioglioma | 21% |
| 52 | gliosarcoma | 21% |
| 53 | Anaplastic astrocytoma | 21% |
| 54 | Anaplastic Oligodendroglioma | 21% |
| 55 | Basal cell carcinoma | 20.9% |
| 56 | Carcinoma, Papillary | 20.9% |
| 57 | Squamous cell carcinoma | 20.9% |
| 58 | Chondrosarcoma | 20.9% |
| 59 | Craniopharyngioma | 20.9% |
| 60 | Cystadenoma | 20.9% |
| 61 | leiomyosarcoma | 20.9% |
| 62 | liposarcoma | 20.9% |
| 63 | Mesothelioma | 20.9% |
| 64 | synovial sarcoma | 20.9% |
| 65 | Neuroectodermal Tumor, Melanotic | 20.9% |
| 66 | Angiomyolipoma | 20.9% |
| 67 | Clear Cell Sarcoma of Soft Tissue | 20.9% |
| 68 | Alveolar Soft Part Sarcoma | 20.9% |
| 69 | Neuroendocrine Tumors | 20.9% |
| 70 | Sarcoma, Myeloid | 20.9% |
| 71 | Carcinoma, Basal Cell | 20.9% |
| 72 | Malignant Carcinoid Syndrome | 20.8% |
| 73 | Neoplasms, Experimental | 20.5% |
| 74 | Glioblastoma | 20.5% |
| 75 | Neuroblastoma | 20.5% |
| 76 | Glioblastoma Multiforme | 20.5% |
| 77 | Ganglioneuroblastoma | 20.3% |
| 78 | Multiple Endocrine Neoplasia | 20.2% |
| 79 | Cystadenocarcinoma | 20.2% |
| 80 | Fibrosarcoma | 20.2% |
| 81 | Osteosarcoma | 20.2% |
| 82 | Mucoepidermoid Carcinoma | 20.2% |
| 83 | Paraneoplastic Encephalomyelitis | 20% |
| 84 | Adenofibroma | 19.9% |
| 85 | Fibroadenoma | 19.9% |
| 86 | Malignant Fibrous Histiocytoma | 19.9% |
| 87 | Trophoblastic Neoplasms | 19.6% |
| 88 | Bowen's Disease | 19.5% |
| 89 | Paraganglioma | 19.5% |
| 90 | Rhabdomyosarcoma | 19.5% |
| 91 | Giant Cell Tumor of Bone | 19.5% |
| 92 | Leukemia, Experimental | 19.5% |
| 93 | Mammary Neoplasms, Experimental | 19.5% |
| 94 | Meningioma | 19.5% |
| 95 | Dermatofibrosarcoma | 19.2% |
| 96 | Dermatofibrosarcoma Protuberans | 19.2% |
| 97 | Pheochromocytoma | 18.9% |
| 98 | Alveolar rhabdomyosarcoma | 18.9% |
| 99 | Choriocarcinoma | 18.6% |
| 100 | Carcinoma, Lobular | 18.6% |
| 101 | Adenoma | 18.5% |
| 102 | Ameloblastoma | 18.5% |
| 103 | Angiokeratoma | 18.5% |
| 104 | Carcinoma | 18.5% |
| 105 | Chordoma | 18.5% |
| 106 | Hemangioma | 18.5% |
| 107 | hemangiopericytoma | 18.5% |
| 108 | Lymphangioma | 18.5% |
| 109 | Mesenchymoma | 18.5% |
| 110 | Nevus | 18.5% |
| 111 | Retroperitoneal Neoplasms | 18.5% |
| 112 | Teratoma | 18.5% |
| 113 | Hepatoblastoma | 18.5% |
| 114 | Mixed Tumor, Mullerian | 18.5% |
| 115 | Germinoma | 18.5% |
| 116 | Teratocarcinoma | 18.5% |
| 117 | Angiofibroma | 18.5% |
| 118 | Sarcoma | 18.5% |
| 119 | Epithelioma | 18.5% |
| 120 | Sarcoma, Experimental | 18.4% |
| 121 | Thymoma | 16.5% |
| 122 | Carcinoid Heart Disease | 16.5% |
| 123 | Multiple Endocrine Neoplasia Type 1 | 16.5% |
| 124 | Leukemia, Plasma Cell | 16.4% |
| 125 | Adenocarcinoma | 16.4% |
| 126 | Carcinoma in Situ | 16.4% |
| 127 | Carcinoma, Transitional Cell | 16.4% |
| 128 | Phyllodes Tumor | 16.4% |
| 129 | Dysgerminoma | 16.4% |
| 130 | Hemangioendothelioma | 16.4% |
| 131 | Lipoma | 16.4% |
| 132 | Myoma | 16.4% |
| 133 | Myxoma | 16.4% |
| 134 | Neuroma | 16.4% |
| 135 | Papilloma | 16.4% |
| 136 | Pseudomyxoma Peritonei | 16.4% |
| 137 | Seminoma | 16.4% |
| 138 | Papillomatosis | 16.4% |
| 139 | Angiolipoma | 16.4% |
| 140 | Myelolipoma | 16.4% |
| 141 | Neoplasms, Bone Tissue | 16.4% |
| 142 | Neoplasms, Fibrous Tissue | 16.4% |
| 143 | Smooth Muscle Tumor | 16.4% |
| 144 | Adenomatosis, Pulmonary | 16.4% |
| 145 | Adenomatous Polyps | 16.4% |
| 146 | Carcinoma, Large Cell | 16.4% |
| 147 | Carcinoma, Small Cell | 16.4% |
| 148 | Desmoplastic Small Round Cell Tumor | 16.4% |
| 149 | Chondroma | 16.4% |
| 150 | Enchondroma | 16.4% |
| 151 | Digestive System Neoplasms | 15.8% |
| 152 | Endocrine Gland Neoplasms | 15.8% |
| 153 | Eye Neoplasms | 15.8% |
| 154 | Nervous System Neoplasms | 15.8% |
| 155 | Leukemia, Radiation-Induced | 15.6% |
| 156 | Adenoid Cystic Carcinoma | 15.3% |
| 157 | fibroma | 15.3% |
| 158 | Fibromatosis | 15.3% |
| 159 | Osteoblastoma | 15.3% |
| 160 | Osteoma | 15.3% |
| 161 | Rhabdomyoma | 15.3% |
| 162 | Chondromatosis | 15.3% |
| 163 | Adenocarcinoma, Clear Cell | 15.3% |
| 164 | Cholangiocarcinoma | 15.3% |
| 165 | Cervical Intraepithelial Neoplasia | 15.3% |
| 166 | Hemangioblastoma | 15.3% |
| 167 | Lymphoma, Extranodal NK-T-Cell | 15.3% |
| 168 | Bone neoplasms | 15% |
| 169 | Lymphocele | 15% |
| 170 | Pancreatic Cyst | 15% |
| 171 | Skin Neoplasms | 15% |
| 172 | Hematologic Neoplasms | 15% |
| 173 | Neoplasms, Radiation-Induced | 15% |
| 174 | Hydatidiform Mole | 14.8% |
| 175 | Fibromatosis, Aggressive | 14.8% |
| 176 | Fibromatosis, Abdominal | 14.8% |
| 177 | Klatskin Tumor | 14.8% |
| 178 | Retinoblastoma | 14.8% |
| 179 | Breast Cyst | 14.6% |
| 180 | Histiocytic Disorders, Malignant | 14.6% |
| 181 | Mediastinal Cyst | 14.6% |
| 182 | Neoplasm Invasiveness | 14.6% |
| 183 | Neoplasm Metastasis | 14.6% |
| 184 | Neoplasm Recurrence, Local | 14.6% |
| 185 | Parovarian Cyst | 14.6% |
| 186 | Pericardial Cyst | 14.6% |
| 187 | Splenic Neoplasms | 14.6% |
| 188 | Thymic Cyst | 14.6% |
| 189 | Carcinogenesis | 14.6% |
| 190 | Myxoid cyst | 14.6% |
| 191 | Metastasis | 14.6% |
| 192 | Carcinoma, Pancreatic Ductal | 14.5% |
| 193 | Parathyroid Neoplasms | 14.3% |
| 194 | Peritoneal Neoplasms | 14.3% |
| 195 | Thyroid Neoplasm | 14.3% |
| 196 | Thyroid carcinoma | 14.3% |
| 197 | Acoustic Neuroma | 14% |
| 198 | Neurofibrosarcoma | 13.9% |
| 199 | Vipoma | 13.8% |
| 200 | Composite Lymphoma | 13.7% |
| 201 | Tracheal Neoplasms | 13.5% |
| 202 | Paraneoplastic Cerebellar Degeneration | 13% |
| 203 | Basal Cell Nevus Syndrome | 12.6% |
| 204 | Tuberous Sclerosis | 12.5% |
| 205 | Optic Nerve Glioma | 12.4% |
| 206 | Endometrial Stromal Sarcoma | 12.4% |
| 207 | Thyroid Nodule | 12.3% |
| 208 | Hepatocellular Adenoma | 12.3% |
| 209 | Mouth Neoplasms | 12.2% |
| 210 | Central Nervous System Neoplasms | 12.2% |
| 211 | Vascular Neoplasms | 12.2% |
| 212 | Thymus Neoplasms | 12.2% |
| 213 | Lymphangioleiomyomatosis | 12.2% |
| 214 | Liver Neoplasms, Experimental | 12.1% |
| 215 | insulinoma | 12.1% |
| 216 | Gastrinoma | 11.9% |
| 217 | Glucagonoma | 11.9% |
| 218 | Genital Neoplasms, Female | 11.9% |
| 219 | Pancreatic Neoplasm | 11.9% |
| 220 | Pancreatic Pseudocyst | 11.9% |
| 221 | Plasmacytoma | 11.9% |
| 222 | Malignant histiocytosis | 11.8% |
| 223 | Lymphatic Metastasis | 11.8% |
| 224 | Neoplasms, Unknown Primary | 11.8% |
| 225 | Leukemic Infiltration | 11.8% |
| 226 | Breast Neoplasms, Male | 11.8% |
| 227 | Histiocytic sarcoma | 11.8% |
| 228 | Neoplasm Micrometastasis | 11.8% |
| 229 | Triple Negative Breast Neoplasms | 11.8% |
| 230 | Nephroblastoma | 11.4% |
| 231 | Esophageal Neoplasms | 10.9% |
| 232 | Limbic Encephalitis | 10.7% |
| 233 | Lymphoma | 10.7% |
| 234 | Meningeal Neoplasms | 10.6% |
| 235 | Corpus Luteum Cyst | 10.6% |
| 236 | Ovarian Cysts | 10.6% |
| 237 | Leukemia, Myelomonocytic, Chronic | 10.5% |
| 238 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 10.5% |
| 239 | Leydig Cell Tumor | 10.3% |
| 240 | Prolactinoma | 10.1% |
| 241 | Growth Hormone-Secreting Pituitary Adenoma | 10.1% |
| 242 | Mastocytoma | 9.9% |
| 243 | Meningeal Carcinomatosis | 9.8% |
| 244 | Mastocytosis, Systemic | 9.8% |
| 245 | Leukemia, Myeloid, Chronic-Phase | 9.8% |
| 246 | Adenomatous Polyposis Coli | 9.5% |
| 247 | Adrenocortical carcinoma | 9.4% |
| 248 | Lambert-Eaton Myasthenic Syndrome | 9.4% |
| 249 | Testicular Neoplasms | 9.4% |
| 250 | Adrenal Gland Neoplasms | 9.1% |
| 251 | Gastrointestinal Neoplasms | 9.1% |
| 252 | Genital Neoplasms, Male | 9.1% |
| 253 | Liver neoplasms | 9.1% |
| 254 | Uveal Neoplasms | 9.1% |
| 255 | Urologic Neoplasms | 8.9% |
| 256 | Mesoblastic Nephroma | 8.8% |
| 257 | Sebaceous Gland Neoplasms | 8.8% |
| 258 | Spinal Neoplasms | 8.8% |
| 259 | Bone Marrow Neoplasms | 8.8% |
| 260 | Hodgkin Disease | 8.6% |
| 261 | Lymphoma, Non-Hodgkin | 8.6% |
| 262 | Choledochal Cyst | 8.6% |
| 263 | Polycystic Ovary Syndrome | 8.6% |
| 264 | granulosa cell tumor | 8.6% |
| 265 | Carcinoma, Ovarian Epithelial | 8.6% |
| 266 | Palatal Neoplasms | 8.4% |
| 267 | Peutz-Jeghers Syndrome | 8.3% |
| 268 | Opsoclonus-Myoclonus Syndrome | 8.1% |
| 269 | Ear Neoplasms | 8.1% |
| 270 | Eyelid Neoplasms | 8.1% |
| 271 | Lung Neoplasms | 8.1% |
| 272 | Pleural Neoplasms | 8.1% |
| 273 | Renal Cell Carcinoma | 8% |
| 274 | Papillary Renal Cell Carcinoma | 8% |
| 275 | Mastocytosis | 8% |
| 276 | Sturge-Weber Syndrome | 8% |
| 277 | Cell Transformation, Viral | 7.9% |
| 278 | Nose Neoplasms | 7.9% |
| 279 | Carcinoma, Endometrioid | 7.9% |
| 280 | Brain Neoplasms | 7.8% |
| 281 | Salivary Gland Neoplasms | 7.8% |
| 282 | Spinal Cord Neoplasms | 7.8% |
| 283 | Tongue Neoplasms | 7.8% |
| 284 | Gastrointestinal Stromal Tumors | 7.8% |
| 285 | Hemangioma, Cavernous | 7.8% |
| 286 | Leukemia, T-Cell | 7.7% |
| 287 | Uterine Neoplasms | 7.7% |
| 288 | Vaginal Neoplasms | 7.7% |
| 289 | Vulvar Neoplasms | 7.7% |
| 290 | Uterine Cancer | 7.7% |
| 291 | Leukemia, B-Cell | 7.7% |
| 292 | Fallopian Tube Neoplasms | 7.7% |
| 293 | neurofibroma | 7.7% |
| 294 | Lymphoma, Follicular | 7.6% |
| 295 | T-Cell Lymphoma | 7.6% |
| 296 | Mantle cell lymphoma | 7.6% |
| 297 | Bronchial Neoplasms | 7.5% |
| 298 | Multiple Pulmonary Nodules | 7.4% |
| 299 | Dupuytren Contracture | 7.3% |
| 300 | Supratentorial Neoplasms | 7.2% |
| 301 | Endometrial Neoplasms | 7.2% |
| 302 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 7.2% |
| 303 | Leukemia, Large Granular Lymphocytic | 7.2% |
| 304 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 7.2% |
| 305 | Lymphoma, T-Cell, Cutaneous | 7.1% |
| 306 | Lymphoma, AIDS-Related | 7.1% |
| 307 | Enteropathy-Associated T-Cell Lymphoma | 7.1% |
| 308 | Primary Effusion Lymphoma | 7.1% |
| 309 | Nasopharyngeal carcinoma | 7.1% |
| 310 | Myelitis, Transverse | 7.1% |
| 311 | Urticaria Pigmentosa | 7.1% |
| 312 | Brain Stem Neoplasms | 6.9% |
| 313 | Mycosis Fungoides | 6.9% |
| 314 | Lymphomatoid Papulosis | 6.9% |
| 315 | Plasmablastic lymphoma | 6.9% |
| 316 | Primary amyloidosis | 6.9% |
| 317 | Denys-Drash Syndrome | 6.8% |
| 318 | Choroid Plexus Papilloma | 6.8% |
| 319 | Pituitary Adenoma | 6.8% |
| 320 | Pituitary Neoplasms | 6.8% |
| 321 | Pharyngeal Neoplasms | 6.5% |
| 322 | Central Nervous System Cysts | 6.3% |
| 323 | Bile Duct Neoplasms | 6.2% |
| 324 | gallbladder neoplasm | 6.2% |
| 325 | Intestinal Neoplasms | 6.2% |
| 326 | Leukoplakia, Oral | 6.2% |
| 327 | Penile Neoplasms | 6.2% |
| 328 | Prostatic Neoplasms | 6.2% |
| 329 | Stomach Neoplasms | 6.2% |
| 330 | Polycythemia Vera | 6.1% |
| 331 | Hypopharyngeal Neoplasms | 5.8% |
| 332 | Pleural Effusion, Malignant | 5.8% |
| 333 | Hypopharyngeal Cancer | 5.8% |
| 334 | Lymphomatoid Granulomatosis | 5.8% |
| 335 | ovarian neoplasm | 5.7% |
| 336 | Parotid Neoplasms | 5.7% |
| 337 | Prostatic Neoplasms, Castration-Resistant | 5.7% |
| 338 | Nelson Syndrome | 5.7% |
| 339 | Tonsillar Neoplasms | 5.5% |
| 340 | Cerebellar Neoplasms | 5.5% |
| 341 | Laryngeal neoplasm | 5.4% |
| 342 | Bladder Neoplasm | 5.1% |
| 343 | Kidney Neoplasm | 5.1% |
| 344 | Ureteral Neoplasms | 5.1% |
| 345 | Urethral Neoplasms | 5.1% |
| 346 | Waldenstrom Macroglobulinemia | 4.9% |
| 347 | Multiple Myeloma | 4.9% |
| 348 | Cecal Neoplasms | 4.7% |
| 349 | Duodenal Neoplasms | 4.7% |
| 350 | Burkitt Lymphoma | 4.7% |
| 351 | Sezary Syndrome | 4.6% |
| 352 | Radicular Cyst | 4.6% |
| 353 | Appendiceal Neoplasms | 4.5% |
| 354 | Colonic Neoplasms | 4.5% |
| 355 | Rectal Neoplasms | 4.5% |
| 356 | Zollinger-Ellison syndrome | 4.2% |
| 357 | Nasopharyngeal Neoplasms | 4.1% |
| 358 | Colorectal Neoplasms | 4% |
| 359 | Anus Neoplasms | 3.8% |
| 360 | Sigmoid Neoplasms | 3.8% |
| 361 | Paranasal Sinus Neoplasms | 3.6% |
| 362 | Maxillary Sinus Neoplasms | 3.4% |
